Trial · NCT03126227
Results by group114
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 114
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | AR101 Powder Provided in Capsules | Subjects with at least 1 AE | 334 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | Placebo Powder | Subjects with at least 1 AE | 159 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | AR101 Powder Provided in Capsules | Mild AE | 171 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | Placebo Powder | Mild AE | 110 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | AR101 Powder Provided in Capsules | Moderate AE | 151 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | Placebo Powder | Moderate AE | 47 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | AR101 Powder Provided in Capsules | Severe AE | 11 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | Placebo Powder | Severe AE | 1 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | AR101 Powder Provided in Capsules | Life Threatening AE | 1 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | Placebo Powder | Life Threatening AE | 0 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | AR101 Powder Provided in Capsules | Death | 0 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | Placebo Powder | Death | 1 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | AR101 Powder Provided in Capsules | Subjects with at least 1 serious adverse event | 2 | Participants | |
| Frequency of Treatment Emergent Adverse Events, Including Serious Adverse Events | Placebo Powder | Subjects with at least 1 serious adverse event | 2 | Participants | |
| Frequency of Premature Discontinuation of Dosing Due to Adverse Events | AR101 Powder Provided in Capsules | 41 | Participants | ||
| Frequency of Premature Discontinuation of Dosing Due to Adverse Events | Placebo Powder | 5 | Participants | ||
| Frequency of Premature Discontinuation of Dosing Due to Chronic/Recurrent Gastrointestinal Adverse Events | AR101 Powder Provided in Capsules | 20 | Participants | ||
| Frequency of Premature Discontinuation of Dosing Due to Chronic/Recurrent Gastrointestinal Adverse Events | Placebo Powder | 0 | Participants | ||
| Proportion of Chronic/Recurrent Gastrointestinal Adverse Events Resolving <2, Between 2-4, Between 4-12, and ≥ 12 Weeks Following Discontinuation of Dosing | AR101 Powder Provided in Capsules | < 2 weeks | 17 | Participants | |
| Proportion of Chronic/Recurrent Gastrointestinal Adverse Events Resolving <2, Between 2-4, Between 4-12, and ≥ 12 Weeks Following Discontinuation of Dosing | Placebo Powder | < 2 weeks | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03126227/results